Amphastar Pharmaceuticals Inc

NASDAQ:AMPH   3:59:53 PM EDT
19.07
-0.12 (-0.62%)
Earnings Announcements

Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Full-Year Ended December 31, 2020

Published: 03/15/2021 20:50 GMT
Amphastar Pharmaceuticals Inc (AMPH) - Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-year Ended December 31, 2020.
Q4 GAAP Loss per Share $0.13.
Q4 Revenue $95.9 Million Versus Refinitiv Ibes Estimate of $88.9 Million.
Q4 Adjusted Non-GAAP Earnings per Share $0.16.
Q4 Earnings per Share Estimate $0.14 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $103.19 Million
Adjusted EPS is expected to be $0.24

Next Quarter Revenue Guidance is expected to be $109.16 Million
Next Quarter EPS Guidance is expected to be $0.29

More details on our Analysts Page.